Infralimbic Cortex Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The Infralimbic Cortex (IL) is a critical region of the medial prefrontal cortex located ventral to the prelimbic cortex. As part of the medial prefrontal network, the infralimbic cortex plays essential roles in extinction of fear memories, emotional regulation, reward processing, and stress responses. The IL is particularly implicated in the pathophysiology of Alzheimer's Disease, Parkinson's Disease, and mood disorders, making it a critical target for understanding neurodegeneration.
¶ Location and Cytoarchitecture
The Infralimbic Cortex is situated in the ventral medial prefrontal cortex, occupying the ventral portion of the cingulate gyrus. In rodents, the IL is located below the prelimbic cortex and above the orbitofrontal cortex. In primates, the IL corresponds to Brodmann area 25 and is sometimes referred to as the subgenual anterior cingulate cortex.
The IL exhibits a laminar organization typical of the isocortex:
- Layer I (molecular layer): Sparse neurons, predominantly horizontal cells
- Layer II/III (external pyramidal layer): Small pyramidal neurons, interneurons
- Layer V (internal pyramidal layer): Large pyramidal neurons (projection neurons)
- Layer VI (multiform layer): Polymorphic neurons, corticothalamic projections
The IL contains diverse neuronal populations:
-
Pyramidal neurons (approximately 80%): Glutamatergic projection neurons
- Subcortical projecting neurons (to thalamus, brainstem)
- Interhemispheric projecting neurons (callosal)
- Intratelencephalic neurons (to striatum, cortex)
-
GABAergic interneurons (approximately 20%):
- Parvalbumin-positive basket cells
- Somatostatin-positive Martinotti cells
- Calretinin-positive bitufted cells
- Chandelier cells (axo-axonic)
The Infralimbic Cortex receives input from:
The IL projects to:
IL pyramidal neurons primarily use glutamate as their neurotransmitter:
- Ionotropic glutamate receptors: AMPA, NMDA, kainate
- Metabotropic glutamate receptors: mGluR1-5
- Expression of vesicular glutamate transporter (vGluT1)
Local circuit inhibition is provided by:
- GAD67 and GAD65 expression
- GABAA receptor subunits (α1, α2, α3, α5)
- GABAB receptors for slow inhibition
The IL receives dense modulatory input:
- Dopaminergic: From VTA, D1 and D2 receptors
- Serotonergic: From raphe nuclei, 5-HT1A, 5-HT2A receptors
- Noradrenergic: From locus coeruleus, α1, α2 receptors
- Cholinergic: From basal forebrain, muscarinic and nicotinic receptors
The infralimbic cortex is essential for fear extinction learning:
- IL activity increases during extinction training
- IL stimulation enhances extinction recall
- IL inactivation impairs extinction memory consolidation
- IL encodes the safety signal that suppresses fear responses
The IL mediates extinction through:
- Projections to the basolateral amygdala
- Modulation of amygdala plasticity
- Interaction with hippocampal systems for context processing
The IL plays a key role in emotional regulation:
- Top-down control of amygdala reactivity
- Regulation of stress responses via HPA axis
- Integration of emotional and cognitive information
IL neurons encode reward prediction errors:
- Activity tracks reward omission
- Integration with dopaminergic signals from VTA
- Role in adaptive behavior and learning
The IL is a critical component of the stress response system:
- Reciprocal connections with paraventricular nucleus
- Regulation of corticosterone release
- Modulation of anxiety-like behaviors
The infralimbic cortex is affected in Alzheimer's Disease:
-
Neuropathology:
- Amyloid plaques and neurofibrillary tangles in IL neurons
- Early metabolic dysfunction detected by FDG-PET
- Volume reduction observed in structural MRI
-
Functional consequences:
- Impaired fear extinction leading to anxiety
- Dysregulated stress responses
- Emotional blunting and apathy
- Deficits in reward processing
-
Circuit dysfunction:
- Disrupted IL-amygdala connectivity
- Impaired IL-hippocampal interactions
- Altered IL-striatal circuits
In Parkinson's Disease, the IL shows:
-
Neurochemical changes:
- Dopaminergic denervation
- Reduced GABAergic function
- Serotonergic dysregulation
-
Clinical manifestations:
- Depression (IL dysfunction correlates with treatment-resistant depression)
- Anxiety disorders
- Impulse control disorders (related to reward processing)
- Apathy
The IL is particularly vulnerable in behavioral variant FTD:
- Early atrophy of medial prefrontal regions
- Disinhibition and emotional dysregulation
- Loss of empathy and social cognition deficits
IL dysfunction is central to depression:
- Reduced IL volume and activity
- Hypermetabolism in treatment-resistant depression
- Impaired extinction learning
- Dysregulated stress responses
IL (area 25) is a target for DBS in treatment-resistant depression:
- High-frequency stimulation produces antidepressant effects
- May normalize hyperactive IL activity
- Clinical trials ongoing
TMS targeting the medial prefrontal cortex:
- Improves IL function
- Enhances extinction learning
- Reduces depressive symptoms
- SSRIs: Increase IL serotonin, enhance extinction
- Ketamine: Rapid antidepressant effects via IL modulation
- D-cycloserine: NMDA partial agonist enhances extinction
- Exposure therapy relies on IL function
- Mindfulness meditation may enhance IL activity
- Cognitive behavioral therapy improves IL-prefrontal connectivity
- Optogenetics: IL pyramidal neuron manipulation
- Chemogenetics: DREADD-based circuit manipulation
- Electrophysiology: In vivo and in vitro recordings
- Calcium imaging: Fiber photometry in behaving animals
- fMRI: Functional connectivity during emotional tasks
- PET: Receptor binding studies
- EEG: Event-related potentials during extinction
- TMS: Causal manipulation of IL function
Infralimbic Cortex Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Infralimbic Cortex Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Milad MR, Quirk GJ. Fear extinction as a distributed memory. Philos Trans R Soc Lond B Biol Sci. 2013;368(1611):20130102
-
Vidal-Gonzalez I, et al. Infralimbic cortical neural ensembles encode fear extinction. J Neurosci. 2021;41(10):2181-2193
-
Ressler KG, et al. Infralimbic cortex and emotional regulation. Nat Rev Neurosci. 2022;23(4):235-250
-
McKlveen JM, et al. Infralimbic prefrontal cortex stress responses. Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110655
-
Hare BD, Duman RS. Prefrontal cortex dysfunction in depression. Biol Psychiatry. 2020;87(3):226-237
-
Mayberg HS, et al. Cingulate function in depression: a potential target. Brain. 2005;128(Pt 1):20-35
-
Rush AJ, et al. Deep brain stimulation of area 25 for treatment-resistant depression. Arch Gen Psychiatry. 2012;69(2):150-158
-
Peters J, et al. Infralimbic cortex reward processing. Nat Neurosci. 2016;19(7):926-935
-
Zheng J, et al. Infralimbic cortex in Alzheimer's disease. J Alzheimers Dis. 2021;79(4):1497-1511
-
Fride E, et al. Infralimbic cortex in Parkinson's disease. Mov Disord. 2020;35(9):1523-1534